Discussion session VI: New therapeutic indications for Cys-LT1 antagonists

C. Lai; H. Magnussen; L. Fabbri; P. Thompson; S. Wenzel; M. Adachi; P. Zimmerman; E. Israel; P. Jeffery; B. Undem; P. Friedmann; J. Leff; S. E. Dahlén; M. Vignola; M. Sears; J. Wilson; C. Picado; M. Peters-Golden; S. T. Holgate; T. Sampson; A. Rubenfeld; J. Willem-Lammers; C. Naspitz; M. Sears

doi:10.1046/j.1472-9725.2001.00037.x

Discussion session VI: New therapeutic indications for Cys-LT₁ antagonists

C. Lai, H. Magnussen, L. Fabbri, P. Thompson, S. Wenzel, M. Adachi, P. Zimmerman, E. Israel, P. Jeffery, B. Undem, P. Friedmann, J. Leff, S. E. Dahlén, M. Vignola, M. Sears, J. Wilson, C. Picado, M. Peters-Golden, S. T. Holgate, T. SampsonA. Rubenfeld, J. Willem-Lammers, C. Naspitz, M. Sears

School of Medicine

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	183-188
Number of pages	6
Journal	Clinical and Experimental Allergy Reviews
Volume	1
Issue number	2
DOIs	https://doi.org/10.1046/j.1472-9725.2001.00037.x
State	Published - 2001

ASJC Scopus subject areas

Immunology and Allergy
Immunology

Access to Document

10.1046/j.1472-9725.2001.00037.x

Cite this

Lai, C., Magnussen, H., Fabbri, L., Thompson, P., Wenzel, S., Adachi, M., Zimmerman, P., Israel, E., Jeffery, P., Undem, B., Friedmann, P., Leff, J., Dahlén, S. E., Vignola, M., Sears, M., Wilson, J., Picado, C., Peters-Golden, M., Holgate, S. T., ... Sears, M. (2001). Discussion session VI: New therapeutic indications for Cys-LT₁ antagonists. Clinical and Experimental Allergy Reviews, 1(2), 183-188. https://doi.org/10.1046/j.1472-9725.2001.00037.x

Lai, C, Magnussen, H, Fabbri, L, Thompson, P, Wenzel, S, Adachi, M, Zimmerman, P, Israel, E, Jeffery, P, Undem, B, Friedmann, P, Leff, J, Dahlén, SE, Vignola, M, Sears, M, Wilson, J, Picado, C, Peters-Golden, M, Holgate, ST, Sampson, T, Rubenfeld, A, Willem-Lammers, J, Naspitz, C & Sears, M 2001, 'Discussion session VI: New therapeutic indications for Cys-LT₁ antagonists', Clinical and Experimental Allergy Reviews, vol. 1, no. 2, pp. 183-188. https://doi.org/10.1046/j.1472-9725.2001.00037.x

@article{f849e128ad3e41758c11fb735ff2e1c5,

title = "Discussion session VI: New therapeutic indications for Cys-LT1 antagonists",

author = "C. Lai and H. Magnussen and L. Fabbri and P. Thompson and S. Wenzel and M. Adachi and P. Zimmerman and E. Israel and P. Jeffery and B. Undem and P. Friedmann and J. Leff and Dahl{\'e}n, {S. E.} and M. Vignola and M. Sears and J. Wilson and C. Picado and M. Peters-Golden and Holgate, {S. T.} and T. Sampson and A. Rubenfeld and J. Willem-Lammers and C. Naspitz and M. Sears",

year = "2001",

doi = "10.1046/j.1472-9725.2001.00037.x",

language = "English (US)",

volume = "1",

pages = "183--188",

journal = "Clinical and Experimental Allergy Reviews",

issn = "1472-9725",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "2",

}

TY - JOUR

T1 - Discussion session VI

T2 - New therapeutic indications for Cys-LT1 antagonists

AU - Lai, C.

AU - Magnussen, H.

AU - Fabbri, L.

AU - Thompson, P.

AU - Wenzel, S.

AU - Adachi, M.

AU - Zimmerman, P.

AU - Israel, E.

AU - Jeffery, P.

AU - Undem, B.

AU - Friedmann, P.

AU - Leff, J.

AU - Dahlén, S. E.

AU - Vignola, M.

AU - Sears, M.

AU - Wilson, J.

AU - Picado, C.

AU - Peters-Golden, M.

AU - Holgate, S. T.

AU - Sampson, T.

AU - Rubenfeld, A.

AU - Willem-Lammers, J.

AU - Naspitz, C.

AU - Sears, M.

PY - 2001

Y1 - 2001

UR - http://www.scopus.com/inward/record.url?scp=17944362925&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=17944362925&partnerID=8YFLogxK

U2 - 10.1046/j.1472-9725.2001.00037.x

DO - 10.1046/j.1472-9725.2001.00037.x

M3 - Article

AN - SCOPUS:17944362925

SN - 1472-9725

VL - 1

SP - 183

EP - 188

JO - Clinical and Experimental Allergy Reviews

JF - Clinical and Experimental Allergy Reviews

IS - 2

ER -

Discussion session VI: New therapeutic indications for Cys-LT1 antagonists

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this

Discussion session VI: New therapeutic indications for Cys-LT₁ antagonists